🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a single institution study of combining decitabine with fludarabine...
Status
Completed
Location
Hackensack University Medical Center - John Theurer Cancer Center
Start Date
2009-05
Trial ID
NCT01455506
Treatments Being Tested
The purpose of this study is to find out if removing a specific type of whi...
Status
Terminated
Location
Memorial SloanKettering Cancer Center
Start Date
2018-07-23
Trial ID
NCT03615144
The primary purpose of this study is to evaluate the pulse wave velocity an...
Status
Active Not Recruiting
Location
Hospital of the University of Pennsylvania
Start Date
2019-11-11
Trial ID
NCT03841097
Treatments Being Tested
Outcomes for patients with severe aplastic anemia (SAA) who are refractory ...
Status
Recruiting
Location
CHU Amiens
Start Date
2022-01-06
Trial ID
NCT05126849
Treatments Being Tested
This phase II clinical trial studies how well treosulfan, thiotepa, fludara...
Status
Recruiting
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2021-05-05
Trial ID
NCT03980769
Neuroblastoma is a malignant tumor of the sympathetic nervous system. It is...
Status
Terminated
Location
Columbia Presbyterian Medical Center, Morgan Stanley Children's Hospital New York Presbyterian
Start Date
2003-11
Trial ID
NCT00670410
Treatments Being Tested
In this study, the investigators test 2 dose levels of thiotepa (5 mg/kg an...
Status
Completed
Location
UF Health Shands Children's Hospital
Start Date
2018-06-15
Trial ID
NCT03513328
Treatments Being Tested
While glucocorticoids and immunosuppressants ameliorate manifestations of a...
Status
Unknown
Location
Charité Universitätsmedizin Berlin
Start Date
1998-01
Trial ID
NCT00742300
Treatments Being Tested
The goal of this clinical research study is to learn if giving romidepsin b...
Status
Completed
Location
The Ohio State University Cancer Center
Start Date
2017-12-08
Trial ID
NCT02512497
Treatments Being Tested
Background: Patients may develop antibodies (human leukocyte antigen \[HLA\...
Status
Terminated
Location
Providence Sacred Heart Medical Center
Start Date
2012-07
Trial ID
NCT01556347
Treatments Being Tested